Skip to main content

Tempus AI, Inc.'s Form 4 filing

Personalis, Inc.PSNL · filed Aug 20, 2024

Accession no.
0001493152-24-033271
Filed
Aug 20, 2024
Trade date
Aug 16, 2024
Filing delay
4 days
Rule 10b5-1 plan
Not checked

This filing lists 3 non-derivative transactions and 2 derivative transactions. Open-market purchases total $17.7M. It was filed 4 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Tempus AI, Inc.CIK 000171711510% Owner

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Aug 16, 2024Common StockXIn-the-money exerciseAcquired+4,609,400$1.50+$6,914,1004,609,400Direct
Aug 16, 2024Common StockXIn-the-money exerciseAcquired+4,609,400$2.50+$11,523,5009,218,800Direct
Aug 16, 2024Common StockPPurchaseAcquired+3,500,000$5.07+$17,745,00012,718,800Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Aug 16, 2024Common StockXIn-the-money exerciseDisposed−4,609,400–F1–0Direct
Aug 16, 2024Common StockXIn-the-money exerciseDisposed−4,609,400–F1–0Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F1

The Reporting Person acquired the warrants as partial consideration for its obligations to the Issuer under that certain Commercialization and Reference Laboratory Agreement, dated November 25, 2023, between the Issuer and the Reporting Person.

Referenced by the price of 2 transactions in Table II.

Read the full filing on SEC EDGAR (opens in a new tab)